Lidocaine Hydrochloride Injection, Solution
Product Images NDC 72603-732

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 72603-732). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lidocaine1percent20mlcarton (Lidocaine1percent20mlcarton)

Lidocaine1percent20mlcarton (Lidocaine1percent20mlcarton)
This text appears to be a description of a medical product or medication. The document mentions details such as the dimensions of the product packaging, Pantone colors used, the content of Lidocaine HCI Injection, and storage information. It also includes information about administration (infiltrator or block use) and mentions the product being non-genic. Additionally, there are details about multiple-dose vials and an unvarnished area of the packaging. The text provides identification codes, the manufacturer's address, and dosage instructions. It would be advisable to consult the original medical documentation or packaging for specific and accurate details.*
FDA Label Image

Lidocaine1percent20mlvial (Lidocaine1percent20mlvial)

Lidocaine1percent20mlvial (Lidocaine1percent20mlvial)
This text appears to be a label for a sterile and non-pyrogenic solution intended for infiltration and nerve block procedures. The solution contains 200 mg/20 mL of a substance and should not be used if it shows precipitation. It can be resterilized by autoclaving. The storage conditions are 20°C to 25°C (68°F to 77°F) as per USP guidelines. The text also mentions not to use the solution for caudal or epidural use. The vial is a multiple-dose vial with a capacity of 20 mL. The label also includes information about the manufacturer, expiration date, lot number, and batch coding instructions.*
FDA Label Image

Lidocaine1percent50mlcarton (Lidocaine1percent50mlcarton)

FDA Label Image

Lidocaine1percent50mlvial (Lidocaine1percent50mlvial)

Lidocaine1percent50mlvial (Lidocaine1percent50mlvial)
This is information found on a pharmaceutical product label. It includes details such as the sterile and nonpyrogenic nature of the product, lot number, expiration date, concentration, storage conditions, and manufacturer information. The product is an HCI Injection, USP with a specific mg/mL concentration. It also mentions restrictions on use, how to resterilize, and the manufacturer's location. Remember to check for solution discoloration or precipitate before use.*
FDA Label Image

Lidocaine2percent20mlcarton (Lidocaine2percent20mlcarton)

Lidocaine2percent20mlcarton (Lidocaine2percent20mlcarton)
Dimensions: 160 x 160 x 70 mm This description provides information on the dimensions of the item, which is 160mm in length, 160mm in width, and 70mm in height. The item is related to Lidocaine HCI Injection, USP, with a concentration of 400 mg/20 ml. It mentions the use of Pantone colors Reflex Blue C, 275 C, and black. The text also includes reference numbers 21003146 and 7260374425.*
FDA Label Image

Lidocaine2percent20mllabel (Lidocaine2percent20mllabel)

Lidocaine2percent20mllabel (Lidocaine2percent20mllabel)
This is a description for Lidocaine Hydrochloride (HCI) Injection, USP. It is a sterile and nonpyrogenic solution that can be resterilized by autoclaving. The solution contains 400 mg of Lidocaine in 20 mL, with a concentration of 20 mg/mL. It is important not to use the solution if it contains a precipitate. The storage temperature range is between 20° to 25°C (68° to 77°F). This product is intended for infiltration and nerve block use and is not suitable for caudal or epidural use. The batch coding, expiration date, and manufacturing details are also provided for reference.*
FDA Label Image

Lidocaine2percent50mlcarton (Lidocaine2percent50mlcarton)

Lidocaine2percent50mlcarton (Lidocaine2percent50mlcarton)
The text appears to be a description of a pharmaceutical product, specifically Lidocaine HCI Injection, USP. It includes details such as dosage instructions, manufacturer information (Asiro Pharma Limited located in Telangana, India), and warnings about the appropriate usage of the product (not for Caudal or Epidural use). The product is intended for Infiltration and Nerve Block procedures, with a typical dosage provided in the packaging. Additionally, there is information about the product being sterile, nonpyrogenic, and suitable for use in a controlled room temperature environment. The text also mentions that the product is not for individual sale and should only be purchased as an unbroken package.*
FDA Label Image

Idocaine2percent50mllabel (Lidocaine2percent50mllabel)

Idocaine2percent50mllabel (Lidocaine2percent50mllabel)
This text contains information about a sterile and nonpyrogenic Lidocaine HCI Injection. It includes details such as the lot number, expiration date, concentration, NDC number, manufacturer's information, storage instructions, and cautions. The product is for infiltration and nerve block only and not for use in caudal or epidural procedures. It mentions the possibility of resterilization by autoclaving.*
FDA Label Image

Lidocainestructure (Lidocainestructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.